Cannabinoid Receptors and Their Ligands: Ligand–Ligand and Ligand–Receptor Modeling Approaches 281Ward SJ, Baizman E, Bell M, Childers S, D’Ambra T, Eissenstat M, Estep K, Haycock D,
Howlett A, Luttinger D, et al (1991) Aminoalkylindoles (AAIs): a new route to the
cannabinoid receptor? NIDA Res Monogr 105:425–426
Wiley JL, Compton DR, Dai D, Lainton JA, Phillips M, Huffman JW, Martin BR (1998)
Structure-activity relationships of indole- and pyrrole-derived cannabinoids. J Phar-
macol Exp Ther 285:995–1004
Wiley JL, Jefferson RG, Grier MC, Mahadevan A, Razdan RK, Martin BR (2001) Novel pyra-
zole cannabinoids: insights into CB(1) receptor recognition and activation. J Pharmacol
Exp Ther 296:1013–1022
Wiley JL, Beletskaya ID, Ng EW, Dai Z, Crocker PJ, Mahadevan A, Razdan RK, Martin BR
(2002) Resorcinol derivatives: a novel template for the development of cannabinoid
CB(1)/CB(2) and CB(2)-selective agonists. J Pharmacol Exp Ther 301:679–689
Xie XQ, Yang DP, Melvin LS, Makriyannis A (1994) Conformational analysis of the prototype
nonclassical cannabinoid CP-47,497, using 2D NMR and computer molecular modeling.
J Med Chem 37:1418–1426
Xie XQ, Eissenstat M, Makriyannis A (1995) Common cannabimimetic pharmacophoric
requirements between aminoalkyl indoles and classical cannabinoids. Life Sci 56:1963–
1970
Xie XQ, Melvin LS, Makriyannis A (1996) The conformational properties of the highly
selective cannabinoid receptor ligand CP-55,940. J Biol Chem 271:10640–10647
Xie XQ, Pavlopoulos S, DiMeglio CM, Makriyannis A (1998) Conformational studies on
a diastereoisomeric pair of tricyclic nonclassical cannabinoids by NMR spectroscopy
and computer molecular modeling. J Med Chem 41:167–174
Xie XQ, Han XW, Chen JZ, Eissenstat M, Makriyannis A (1999) High-resolution NMR and
computer modeling studies of the cannabimimetic aminoalkylindole prototype WIN-
55212-2. J Med Chem 42:4021–4027
Xie XQ, Chen JZ, Billings EM (2003) 3D structural model of the G-protein-coupled cannabi-
noid CB2 receptor. Proteins 53:307–319